Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein kinase, cAMP-dependent, regulatory subunit type II beta pseudogene (ENSG00000255381) is a genomic DNA sequence similar to the functional PRKAR2B gene but is classified as a pseudogene, meaning it does not produce a functional protein product. Pseudogenes generally arise from duplication or retrotransposition events and are non-functional; they are not typically involved in drug targeting, disease association, or cellular signaling. This distinguishes it from the functional PRKAR2B gene, which encodes a regulatory subunit of protein kinase A and is important in cAMP signaling, energy balance, and other processes[1][2][3]. The PRKAR2B pseudogene is not a therapeutic target, receptor, enzyme, transporter, or regulator in the sense relevant to pharmacology or disease. If the intention was to refer to the functional protein PRKAR2B (protein kinase, cAMP-dependent, regulatory subunit type II beta), that is a recognized signal transduction enzyme with disease associations and therapeutic implications[1][4][7]. However, ENSG00000255381 is explicitly a pseudogene and not functionally equivalent to PRKAR2B.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein kinase, cAMP-dependent, regulatory subunit type II beta pseudogene.